NVAX RSI Chart
Last 7 days
-11.1%
Last 30 days
13.0%
Last 90 days
-7.1%
Trailing 12 Months
-18.9%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 1.4B | 1.6B | 1.0B | 983.7M |
2022 | 1.4B | 1.3B | 1.8B | 2.0B |
2021 | 919.5M | 1.2B | 1.2B | 1.1B |
2020 | 18.1M | 50.2M | 204.8M | 475.6M |
2019 | 28.6M | 21.2M | 16.0M | 18.7M |
2018 | 35.1M | 39.2M | 38.6M | 34.3M |
2017 | 16.8M | 21.0M | 26.2M | 31.2M |
2016 | 30.6M | 19.1M | 15.8M | 15.4M |
2015 | 33.1M | 38.8M | 37.1M | 36.3M |
2014 | 24.5M | 29.3M | 32.7M | 30.7M |
2013 | 21.3M | 17.7M | 16.7M | 20.9M |
2012 | 18.5M | 22.6M | 23.4M | 22.1M |
2011 | 2.2M | 4.1M | 8.9M | 14.7M |
2010 | 0 | 331.0K | 337.0K | 343.0K |
2009 | 0 | 0 | 0 | 325.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 10, 2024 | dubovsky filip | sold (taxes) | -14,153 | 5.45 | -2,597 | president, r&d |
Mar 10, 2024 | kelly james patrick | sold (taxes) | -12,131 | 5.45 | -2,226 | evp, cfo and treasurer |
Mar 10, 2024 | trizzino john | sold (taxes) | -12,131 | 5.45 | -2,226 | president and coo |
Mar 10, 2024 | dubovsky filip | acquired | - | - | 5,376 | president, r&d |
Mar 10, 2024 | kelly james patrick | acquired | - | - | 4,608 | evp, cfo and treasurer |
Mar 10, 2024 | trizzino john | acquired | - | - | 4,608 | president and coo |
Mar 07, 2024 | kelly james patrick | sold (taxes) | -33,127 | 5.61 | -5,905 | evp, cfo and treasurer |
Mar 07, 2024 | dubovsky filip | sold (taxes) | -52,689 | 5.61 | -9,392 | president, r&d |
Mar 07, 2024 | dubovsky filip | acquired | - | - | 19,444 | president, r&d |
Mar 07, 2024 | trizzino john | sold (taxes) | -78,287 | 5.61 | -13,955 | evp, cco and cbo |
Which funds bought or sold NVAX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | added | 40.93 | -1,143 | 16,262 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 26.05 | -13,744,400 | 69,888,300 | -% |
Mar 08, 2024 | ICA Group Wealth Management, LLC | new | - | 960 | 960 | -% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 205 | 4,195,110 | 8,291,850 | -% |
Feb 29, 2024 | Tortoise Investment Management, LLC | unchanged | - | -61.00 | 120 | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | added | 8.94 | -87,375 | 227,232 | -% |
Feb 21, 2024 | Raleigh Capital Management Inc. | unchanged | - | -4.00 | 10.00 | -% |
Feb 16, 2024 | GSA CAPITAL PARTNERS LLP | sold off | -100 | -87,000 | - | -% |
Feb 16, 2024 | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | new | - | 4,910 | 4,910 | -% |
Feb 16, 2024 | PRICE T ROWE ASSOCIATES INC /MD/ | reduced | -9.88 | -155,000 | 231,000 | -% |
Unveiling Novavax Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Novavax Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 42.3B | 6.8B | -8.96 | 6.17 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 19.4B | 1.8B | -44.17 | 10.64 | ||||
BMRN | 16.7B | 2.4B | 99.73 | 6.91 | ||||
INCY | 12.8B | 3.7B | 21.46 | 3.47 | ||||
MID-CAP | ||||||||
APLS | 7.1B | 396.6M | -13.34 | 17.78 | ||||
BBIO | 5.4B | - | -8.31 | 60.35 | ||||
AXSM | 3.8B | 270.6M | -15.68 | 13.86 | ||||
ARWR | 3.6B | 240.7M | -11.98 | 14.77 | ||||
ACAD | 3.0B | 726.4M | -48.93 | 4.13 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 398.2M | 26.85 | 4.82 | ||||
NVAX | 678.8M | 983.7M | -1.25 | 0.69 | ||||
CRBP | 373.2M | 881.7K | -8.37 | 466.16 | ||||
INO | 304.5M | 4.9M | -2.25 | 62.57 | ||||
IBIO | 11.8M | 2.1M | -0.43 | 2.14 |
Novavax Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 55.8% | 291,342,000 | 186,986,000 | 424,426,000 | 80,951,000 | 357,399,000 | 734,577,000 | 185,925,000 | 703,971,000 | 222,200,000 | 178,844,000 | 298,017,000 | 447,229,000 | 279,659,000 | 157,024,000 | 35,538,000 | 3,377,000 | 8,816,000 | 2,507,000 | 3,357,000 | 3,982,000 | 6,127,000 |
Cost Of Revenue | 56.7% | 154,976,000 | 98,929,000 | 55,777,000 | 34,086,000 | 181,765,000 | 434,593,000 | 271,077,000 | 15,204,000 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Costs and Expenses | 51.9% | 474,910,000 | 312,618,000 | 368,969,000 | 393,719,000 | 601,278,000 | 861,766,000 | 668,885,000 | 494,679,000 | 1,047,171,000 | 485,988,000 | 643,846,000 | 655,861,000 | 462,512,000 | 350,966,000 | 52,565,000 | 26,274,000 | 37,521,000 | 17,494,000 | 40,023,000 | 44,205,000 | 52,639,000 |
S&GA Expenses | 44.5% | 155,237,000 | 107,460,000 | 93,717,000 | 112,532,000 | 161,663,000 | 122,876,000 | 108,160,000 | 95,992,000 | 84,214,000 | 77,793,000 | 73,161,000 | 63,190,000 | 61,313,000 | 56,879,000 | 17,719,000 | 9,379,000 | 8,180,500 | 7,899,000 | 9,606,000 | 8,732,000 | 9,224,000 |
R&D Expenses | 55.0% | 164,697,000 | 106,229,000 | 219,475,000 | 247,101,000 | 257,850,000 | 304,297,000 | 289,648,000 | 383,483,000 | 962,957,000 | 408,195,000 | 570,685,000 | 592,671,000 | 401,199,000 | 294,087,000 | 34,846,000 | 16,895,000 | 29,340,500 | 18,611,000 | 30,417,000 | 35,473,000 | 43,415,000 |
EBITDA Margin | -4.4% | -0.50 | -0.47 | -0.33 | -0.81 | -0.31 | -0.68 | -1.09 | -0.89 | -1.47 | -0.86 | -0.78 | -0.64 | - | - | - | - | - | - | - | - | - |
Interest Expenses | 44.0% | 4,117,000 | 2,859,000 | 3,124,000 | 4,316,000 | 4,601,000 | 4,169,000 | 6,234,000 | 4,876,000 | 5,138,000 | 5,182,000 | 5,968,000 | 4,839,000 | 3,879,000 | 4,460,000 | 3,403,000 | 3,403,000 | 3,403,000 | 3,403,000 | 3,403,000 | 3,403,000 | 3,403,000 |
Income Taxes | 342.2% | 1,688,000 | -697,000 | -143,000 | 1,183,000 | -2,260,000 | 2,472,000 | 1,418,000 | 2,662,000 | 16,609,000 | 6,041,000 | 3,548,000 | 3,017,000 | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | -34.4% | -176,701,000 | -131,473,000 | 57,865,000 | -292,722,000 | -184,509,000 | -166,141,000 | -509,067,000 | 206,070,000 | -829,675,000 | -316,390,000 | -348,769,000 | -219,702,000 | -177,564,000 | -197,310,000 | -17,521,000 | - | - | - | - | - | - |
EBT Margin | -5.2% | -0.55 | -0.52 | -0.37 | -0.85 | -0.33 | -0.70 | -1.12 | -0.92 | -1.50 | -0.88 | -0.80 | -0.67 | - | - | - | - | - | - | - | - | - |
Net Income | -36.4% | -178,389,000 | -130,776,000 | 58,008,000 | -293,905,000 | -182,249,000 | -168,613,000 | -510,485,000 | 203,408,000 | -846,284,000 | -322,431,000 | -352,317,000 | -222,719,000 | -177,564,000 | -197,310,000 | -17,521,000 | -25,864,000 | -31,830,000 | -18,043,000 | -39,603,000 | -43,218,000 | -49,334,000 |
Net Income Margin | -6.0% | -0.55 | -0.52 | -0.37 | -0.85 | -0.33 | -0.72 | -1.14 | -0.94 | -1.52 | -0.89 | -0.80 | -0.67 | - | - | - | - | - | - | - | - | - |
Free Cashflow | -345.3% | -176,800,000 | -39,700,000 | -193,949,000 | -347,604,000 | -139,790,000 | -60,719,000 | -184,610,333 | -102,217,333 | -356,115,333 | -155,850,333 | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 8.5% | 1,797 | 1,657 | 1,685 | 1,543 | 2,259 | 2,267 | 2,623 | 2,835 | 2,577 | 2,566 | 2,750 | 2,608 | 1,582 | 944 | 932 | 328 | 173 | 165 | 189 | 221 | 208 |
Current Assets | 13.6% | 1,144 | 1,007 | 1,128 | 971 | 1,703 | 1,760 | 2,136 | 2,347 | 2,155 | 2,174 | 2,355 | 2,247 | 1,248 | 671 | 636 | 255 | 97.00 | 89.00 | 110 | 123 | 119 |
Cash Equivalents | -12.7% | 569 | 651 | 506 | 625 | 1,337 | 1,293 | 1,388 | 1,584 | 1,515 | 1,947 | 2,123 | 2,029 | 649 | 402 | 532 | 187 | 82.00 | 76.00 | 78.00 | 106 | 82.00 |
Inventory | -40.1% | 42.00 | 70.00 | 23.00 | 34.00 | 37.00 | 82.00 | 256 | 107 | 9.00 | - | - | - | - | - | - | - | - | - | - | - | - |
Net PPE | 1.6% | 306 | 301 | 300 | 307 | 294 | 256 | 255 | 247 | 226 | 215 | 213 | 192 | 180 | 132 | 115 | 11.00 | 11.00 | 12.00 | 13.00 | 27.00 | 28.00 |
Goodwill | 3.0% | 127 | 124 | 128 | 130 | 126 | 118 | 123 | 131 | 131 | 132 | 134 | 131 | 135 | 127 | 119 | 50.00 | 51.00 | 50.00 | 51.00 | 51.00 | 52.00 |
Liabilities | 7.7% | 2,514 | 2,336 | 2,440 | 2,438 | 2,893 | 2,833 | 3,040 | 2,770 | 2,928 | 2,105 | 2,004 | 1,569 | 955 | 638 | 548 | 352 | 359 | 355 | 375 | 372 | 376 |
Current Liabilities | 11.3% | 1,635 | 1,469 | 1,596 | 1,919 | 2,460 | 1,668 | 2,156 | 2,261 | 2,390 | 1,753 | 1,652 | 1,209 | 580 | 239 | 213 | 19.00 | 26.00 | 22.00 | 41.00 | 31.00 | 46.00 |
Shareholder's Equity | -Infinity% | -716 | - | - | - | -634 | - | - | 65.00 | -351 | 461 | 746 | 1,039 | 627 | 106 | 185 | - | - | - | - | - | - |
Retained Earnings | -3.8% | -4,820 | -4,642 | -4,511 | -4,569 | -4,275 | -4,093 | -3,925 | -3,414 | -3,617 | -2,771 | -2,449 | -2,096 | -1,874 | -1,696 | -1,499 | -1,457 | -1,431 | -1,399 | -1,381 | -1,342 | -1,299 |
Additional Paid-In Capital | 3.1% | 4,192 | 4,067 | 3,856 | 3,768 | 3,738 | 3,641 | 3,605 | 3,566 | 3,352 | 3,311 | 3,237 | 3,180 | 2,535 | 1,849 | 1,699 | 1,450 | 1,261 | 1,226 | 1,211 | 1,202 | 1,145 |
Shares Outstanding | 17.5% | 140 | 119 | 94.00 | 86.00 | 86.00 | 78.00 | 78.00 | 76.00 | 74.00 | 75.00 | 74.00 | 73.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | 699 | - | - | - | 4,010 | - | - | - | 15,697 | - | - | - | 5,079 | - | - | - | 138 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -345.3% | -176 | -39.70 | -171 | -325 | -117 | -38.71 | -170 | -88.51 | -342 | -142 | 144 | 663 | -128 | -6.50 | 116 | -23.11 | -23.74 | -32.26 | -30.01 | -50.61 | -45.27 |
Share Based Compensation | -24.6% | 16.00 | 21.00 | 20.00 | 29.00 | 28.00 | 32.00 | 38.00 | 33.00 | 32.00 | 45.00 | 53.00 | 53.00 | 50.00 | 66.00 | 8.00 | 4.00 | 4.00 | 3.00 | 5.00 | 6.00 | 4.00 |
Cashflow From Investing | 50.6% | -9.08 | -18.39 | -7.78 | -23.56 | -22.06 | -29.52 | -24.58 | -16.83 | -16.36 | -12.19 | -12.90 | 142 | -31.12 | -100 | -188 | -57.73 | -0.22 | 18.00 | 2.00 | 19.00 | 48.00 |
Cashflow From Financing | -49.1% | 100 | 197 | 61.00 | -354 | 191 | -30.98 | 5.00 | 160 | -60.71 | -15.72 | -38.84 | 577 | 405 | -22.39 | 417 | 186 | 30.00 | 12.00 | 0.00 | 56.00 | 4.00 |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Revenue: | |||
Revenues | $ 983,705 | $ 1,981,872 | $ 1,146,290 |
Expenses: | |||
Cost of sales | 343,768 | 902,639 | 0 |
Research and development | 737,502 | 1,235,278 | 2,534,508 |
Selling, general, and administrative | 468,946 | 488,691 | 298,358 |
Total expenses | 1,550,216 | 2,626,608 | 2,832,866 |
Loss from operations | (566,511) | (644,736) | (1,686,576) |
Other income (expense): | |||
Interest expense | (14,416) | (19,880) | (21,127) |
Other income (expense) | 37,896 | 10,969 | (6,833) |
Loss before income tax expense | (543,031) | (653,647) | (1,714,536) |
Income tax expense | (2,031) | (4,292) | (29,215) |
Net loss | $ (545,062) | $ (657,939) | $ (1,743,751) |
Net loss per share: | |||
Basic (in usd per share) | $ (5.41) | $ (8.42) | $ (23.44) |
Diluted (in usd per share) | $ (5.41) | $ (8.42) | $ (23.44) |
Weighted average number of common shares outstanding: | |||
Basic (in shares) | 100,768 | 78,183 | 74,400 |
Diluted (in shares) | 100,768 | 78,183 | 74,400 |
Product sales | |||
Revenue: | |||
Revenues | $ 531,389 | $ 1,554,961 | $ 0 |
Grants | |||
Revenue: | |||
Revenues | 427,323 | 382,921 | 948,709 |
Royalties and other | |||
Revenue: | |||
Revenues | $ 24,993 | $ 43,990 | $ 197,581 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 568,505 | $ 1,336,883 |
Restricted cash | 10,424 | 10,303 |
Accounts receivable | 297,240 | 82,375 |
Inventory | 41,696 | 36,683 |
Prepaid expenses and other current assets | 226,023 | 237,147 |
Total current assets | 1,143,888 | 1,703,391 |
Property and equipment, net | 305,771 | 294,247 |
Right of use asset, net | 185,218 | 106,241 |
Goodwill | 127,454 | 126,331 |
Other non-current assets | 35,159 | 28,469 |
Total assets | 1,797,490 | 2,258,679 |
Current liabilities: | ||
Accounts payable | 132,610 | 216,517 |
Accrued expenses | 394,668 | 591,158 |
Deferred revenue | 241,310 | 370,137 |
Current portion of finance lease liabilities | 5,142 | 27,196 |
Convertible notes payable | 0 | 324,881 |
Other current liabilities | 861,408 | 930,055 |
Total current liabilities | 1,635,138 | 2,459,944 |
Deferred revenue | 622,210 | 179,414 |
Convertible notes payable | 168,016 | 166,466 |
Non-current finance lease liabilities | 55,923 | 31,238 |
Other non-current liabilities | 33,130 | 55,695 |
Total liabilities | 2,514,417 | 2,892,757 |
Commitments and contingencies (Note 16) | ||
Preferred stock, $0.01 par value, 2,000,000 shares authorized at December 31, 2023 and 2022; no shares issued and outstanding at December 31, 2023 and 2022 | 0 | 0 |
Stockholders’ deficit: | ||
Common stock, $0.01 par value, 600,000,000 shares authorized at December 31, 2023 and 2022; and 140,506,093 shares issued and 139,505,770 shares outstanding at December 31, 2023 and 86,806,554 shares issued and 86,039,923 shares outstanding at December 31, 2022 | 1,405 | 868 |
Additional paid-in capital | 4,192,164 | 3,737,979 |
Accumulated deficit | (4,820,951) | (4,275,889) |
Treasury stock, 1,000,323 shares, cost basis at December 31, 2023 and 766,631 shares, cost basis at December 31, 2022 | (92,267) | (90,659) |
Accumulated other comprehensive income (loss) | 2,722 | (6,377) |
Total stockholders’ deficit | (716,927) | (634,078) |
Total liabilities and stockholders’ deficit | $ 1,797,490 | $ 2,258,679 |